leisure time -WSS

leisure time

author：explore 2025-09-27 12:35:13 - browse：8137

Ron Wyden, left, and Mike Crapo, right. -- health policy coverage from STAT — Sens. Ron Wyden and Mike Crapo passed a new slate of pharmacy benefit manager reforms through the Finance Committee. Kevin Dietsch/Getty Images

WASHINGTON — A prominent Senate panel on Wednesday passed a new package of health policy reforms that would rein in certain pharmacy middlemen practices and ensure Medicare patients aren’t paying more than insurers do for medications.

The package passed the committee 26-0 with no amendments added. Sen. Ron Johnson (R-Wis.) didn’t vote.

The package, crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) also includes policy on a broad range of health care priorities, including substance abuse and mental health care and extensions to provider pay. The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Sophia Smith scores twice for US in in 3

WSS

How many hemophilia patients actually want gene therapy?

Novartis develops a rapidly manufactured CAR

EPA limits use of carcinogenic gas for sterilizing medical devices

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

President Biden's budget: Here's what you might have missed

RaDonda Vaught links Vanderbilt hospital issues to patient death

knowledge

leisure time

focus

United colonoscopy coverage change 'may cost lives,' doctors say

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

ChatGPT in medicine: STAT answers readers' burning questions

Men with early prostate cancer can safely opt out of treatment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How many hemophilia patients actually want gene therapy?

Duchenne breakthrough therapy leaves behind pioneering families

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

Drug repurposing or repositioning? The language matters

Why depression after traumatic brain injury is distinct

knowledge

4 missing after record

President Biden's budget: Here's what you might have missed

Men with early prostate cancer can safely opt out of treatment

Clinic falsely told dozens they had Alzheimer's, suits say

FDA approves first blood sugar monitor without finger pricks

Pushing for an NIH office for post

hotspot

leisure time

explore

focus